Title : Alisertib shows negligible potential for perpetrating pharmacokinetic drug-drug interactions on ABCB1, ABCG2 and cytochromes P450, but acts as dual-activity resistance modulator through the inhibition of ABCC1 transporter.

Pub. Date : 2022 Jan 1

PMID : 34896433






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Drug combination studies revealed the capability of alisertib to synergistically antagonize ABCC1-mediated resistance to daunorubicin. Daunorubicin ATP binding cassette subfamily C member 1 Homo sapiens